If it seems there is another new drug given FDA approval for treatment of type 2 diabetes every week, you are not imaging things. Last week, once-a-week injection formula BYDUREON was approved.
This week the FDA approved another once-daily pill to help people with type 2 diabetes control their blood sugar levels. The new drug is a combination of sitagliptin and metformin and MERCK is marketing it under the brand name Janumet XR®, the XR is for extended release. (Published site)
